Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fisetin, a phytochemical, potentiates sorafenib-induced apoptosis and abrogates tumor growth in athymic nude mice implanted with BRAF-mutated melanoma cells
Harish C. Pal, Ronald Baxter, Katherine M Hunt, et al.
Oncotarget (2015) Vol. 6, Iss. 29, pp. 28296-28311
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma
Zhongjie Li, Hui-Qi Dai, Xiaowei Huang, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 2, pp. 301-310
Open Access | Times Cited: 228
Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
Dharambir Kashyap, Vivek Kumar Garg, Hardeep Singh Tuli, et al.
Biomolecules (2019) Vol. 9, Iss. 5, pp. 174-174
Open Access | Times Cited: 215
Advances on Natural Polyphenols as Anticancer Agents for Skin Cancer
Soraya Sajadimajd, Roodabeh Bahramsoltani, Amin Iranpanah, et al.
Pharmacological Research (2019) Vol. 151, pp. 104584-104584
Open Access | Times Cited: 196
Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies
Lynda Wyld, Ilaria Bellantuono, Tamar Tchkonia, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2134-2134
Open Access | Times Cited: 187
Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy
Jean Christopher Chamcheu, Tithi Roy, Mohammad B. Uddin, et al.
Cells (2019) Vol. 8, Iss. 8, pp. 803-803
Open Access | Times Cited: 158
A renewed concept on the MAPK signaling pathway in cancers: Polyphenols as a choice of therapeutics
Juhaer Anjum, Saikat Mitra, Rajib Das, et al.
Pharmacological Research (2022) Vol. 184, pp. 106398-106398
Closed Access | Times Cited: 80
Potential therapeutic targets of epithelial–mesenchymal transition in melanoma
Ross Pearlman, Mary Katherine Montes de, Harish C. Pal, et al.
Cancer Letters (2017) Vol. 391, pp. 125-140
Open Access | Times Cited: 149
Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy
Dharambir Kashyap, Ajay Sharma, Katrin Sak, et al.
Life Sciences (2017) Vol. 194, pp. 75-87
Closed Access | Times Cited: 139
Dietary flavonoid fisetin for cancer prevention and treatment
Rahul K. Lall, Vaqar M. Adhami, Hasan Mukhtar
Molecular Nutrition & Food Research (2016) Vol. 60, Iss. 6, pp. 1396-1405
Open Access | Times Cited: 131
Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma
Feng Liu, Frank L. Meyskens
Molecular Nutrition & Food Research (2016) Vol. 60, Iss. 6, pp. 1264-1274
Open Access | Times Cited: 123
Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives
Elina Khatoon, Kishore Banik, Choudhary Harsha, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 306-339
Closed Access | Times Cited: 121
Phytotherapeutics in cancer invasion and metastasis
Bahare Salehi, Paolo Zucca, Mehdi Sharifi‐Rad, et al.
Phytotherapy Research (2018) Vol. 32, Iss. 8, pp. 1425-1449
Open Access | Times Cited: 113
Resveratrol enhances the efficacy of sorafenib mediated apoptosis in human breast cancer MCF7 cells through ROS, cell cycle inhibition, caspase 3 and PARP cleavage
Arindam Mondal, Lunawati L. Bennett
Biomedicine & Pharmacotherapy (2016) Vol. 84, pp. 1906-1914
Closed Access | Times Cited: 112
Oxidative stress and antioxidants in the pathophysiology of malignant melanoma
Elena Obrador, Feng Liu, Ryan W. Dellinger, et al.
Biological Chemistry (2018) Vol. 400, Iss. 5, pp. 589-612
Open Access | Times Cited: 105
Fisetin and Its Role in Chronic Diseases
Harish C. Pal, Ross Pearlman, Farrukh Afaq
Advances in experimental medicine and biology (2016), pp. 213-244
Closed Access | Times Cited: 102
A review on the chemotherapeutic potential of fisetin: In vitro evidences
Kiruthika Sundarraj, Azhwar Raghunath, Ekambaram Perumal
Biomedicine & Pharmacotherapy (2017) Vol. 97, pp. 928-940
Closed Access | Times Cited: 100
Recent advances in phytochemical-based Nano-formulation for drug-resistant Cancer
Mahesh P. More, Sagar R. Pardeshi, Chandrakantsing V. Pardeshi, et al.
Medicine in Drug Discovery (2021) Vol. 10, pp. 100082-100082
Open Access | Times Cited: 70
Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review
Robert Kubina, Kamil Krzykawski, Agata Kabała‐Dzik, et al.
Nutrients (2022) Vol. 14, Iss. 13, pp. 2604-2604
Open Access | Times Cited: 40
The Dietary Flavonoid Fisetin Causes Cell Cycle Arrest, Caspase‐Dependent Apoptosis, and Enhanced Cytotoxicity of Chemotherapeutic Drugs in Triple‐Negative Breast Cancer Cells
Matthew L Smith, Kaylee Murphy, Carolyn D. Doucette, et al.
Journal of Cellular Biochemistry (2016) Vol. 117, Iss. 8, pp. 1913-1925
Closed Access | Times Cited: 81
Exploring the molecular targets of dietary flavonoid fisetin in cancer
Deeba N. Syed, Vaqar M. Adhami, Naghma Khan, et al.
Seminars in Cancer Biology (2016) Vol. 40-41, pp. 130-140
Open Access | Times Cited: 79
TNF-alpha and metalloproteases as key players in melanoma cells aggressiveness
Stefania Rossi, Martina Cordella, Claudio Tabolacci, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 79
Effect of fisetin supplementation on inflammatory factors and matrix metalloproteinase enzymes in colorectal cancer patients
Alireza Farsad Naeimi, Mohammad Alizadeh, Ali Esfahani, et al.
Food & Function (2018) Vol. 9, Iss. 4, pp. 2025-2031
Closed Access | Times Cited: 77
Phytochemicals for the Management of Melanoma
Harish C. Pal, Katherine M Hunt, Ariana C. Diamond, et al.
Mini-Reviews in Medicinal Chemistry (2016) Vol. 16, Iss. 12, pp. 953-979
Open Access | Times Cited: 75
The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways
Thamaraiselvan Rengarajan, Nik Soriani Yaacob
European Journal of Pharmacology (2016) Vol. 789, pp. 8-16
Closed Access | Times Cited: 74
Fisetin inhibits laryngeal carcinoma through regulation of AKT/NF-κB/mTOR and ERK1/2 signaling pathways
Xijun Zhang, Shenshan Jia
Biomedicine & Pharmacotherapy (2016) Vol. 83, pp. 1164-1174
Closed Access | Times Cited: 73
Page 1 - Next Page

Scroll to top